Abstract | PURPOSE: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage and administration of pregabalin are reviewed. SUMMARY: CONCLUSION:
Pregabalin may be beneficial for the treatment of neuropathic pain or partial-onset seizures in patients who do not respond to conventional treatments or cannot tolerate their adverse effects.
|
Authors | Matthew L Blommel, Amy L Blommel |
Journal | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
(Am J Health Syst Pharm)
Vol. 64
Issue 14
Pg. 1475-82
(Jul 15 2007)
ISSN: 1535-2900 [Electronic] England |
PMID | 17617497
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anticonvulsants
- Pregabalin
- gamma-Aminobutyric Acid
|
Topics |
- Animals
- Anticonvulsants
(chemistry, pharmacology, therapeutic use)
- Diabetic Neuropathies
(drug therapy, epidemiology, metabolism)
- Epilepsy, Partial, Sensory
(drug therapy, epidemiology, metabolism)
- Humans
- Pain
(drug therapy, epidemiology, metabolism)
- Pregabalin
- gamma-Aminobutyric Acid
(analogs & derivatives, chemistry, pharmacology, therapeutic use)
|